CELiD BioTechnologies Inc.

CELiD BioTechnologies Inc.

Biotechnology-Research

Rockville, Maryland
United States
Company Tagline

CELiD and rAAV production company, currently #hiring lab technician!

Industry Category
Biotechnology-Research
Company Description

CELiD BioTechnologies Inc. is a leading biotechnology company focused on advancing gene therapy for genetic metabolic disorders and rare diseases. CELiD BioTechnologies Inc. is dedicated to developing innovative, non-viral gene therapy medicines, building upon the groundbreaking discovery of closed-ended linear duplex DNA (CELiD DNA or ceDNA). This novel platform holds significant potential for curing diseases and developing vaccines.

CELiD BioTechnologies Inc. commercially produces customized ceDNA and rAAV vectors, leveraging licenses from influential research conducted at the National Institutes of Health (NIH). Located at 13 Taft Ct, Rockville, Maryland 20850, US, CELiD BioTechnologies Inc. is committed to pioneering advancements in biotechnology and gene therapy.

CELiD BioTechnologies Inc. continues to drive innovation in the field, striving to create breakthrough treatment options. We invite the manager of CELiD BioTechnologies Inc. to create a customized and exclusive company showcase and product listing on our platform to further enhance your market presence.

CELiD BioTechnologies Inc. est une entreprise de biotechnologie de premier plan axée sur l'avancement de la thérapie génique pour les troubles métaboliques génétiques et les maladies rares. CELiD BioTechnologies Inc. se consacre au développement de médicaments de thérapie génique non virale innovants, s'appuyant sur la découverte révolutionnaire de l'ADN duplex linéaire à extrémité fermée (ADN CELiD ou ceDNA). Cette nouvelle plateforme offre un potentiel important pour guérir les maladies et développer des vaccins.

CELiD BioTechnologies Inc. produit commercialement des vecteurs ceDNA et rAAV personnalisés, tirant parti des licences de recherches influentes menées aux National Institutes of Health (NIH). Située au 13 Taft Ct, Rockville, Maryland 20850, États-Unis, CELiD BioTechnologies Inc. s'engage à être pionnière dans les avancées en biotechnologie et en thérapie génique.

CELiD BioTechnologies Inc. continue de stimuler l'innovation dans le domaine, en s'efforçant de créer des options de traitement révolutionnaires. Nous invitons le directeur de CELiD BioTechnologies Inc. à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin d'améliorer davantage votre présence sur le marché.

Key Personnel / Employees

Compare Companies Side by Side

Compare CELiD BioTechnologies Inc. with 1 companies in Biotechnology-Research

2 Companies
Comparison Field
CELiD BioTechnologies Inc.
CELiD BioTechnologies Inc...
Main Company
NewBiologix
NewBiologix
View Profile
Founded Year
2023
Company Size
11-50
City
Rockville, Maryland Epalinges, Switzerland
Country
United States
Skills & Keywords Comparing with main company
9 Total Skills
Gene Therapy Biotechnology rAAV Vectors ceDNA Genetic Disorders Vaccine Development Metabolic Disorders rAAV gene therapy
18 Total 18 Unique
Unique Skills:
ATMPs bioinformatics biologics capsid optimization cell therapy epigenetic +12
2
Total Companies
2023
Oldest Founded
1
Countries
27
Unique Skills

Similar Companies

Other organizations in the same industry

TrueHb
Biotechnology-Research

Leveraging cutting edge biotechnology to eliminate anemia from the world.

Delhi, New Delhi
India
Unibiome (Peer To Peer Probiotics)
Biotechnology-Research
Paris, Ile de France
France
CiberMed
Biotechnology-Research

Providing a best-in-class digital cytometry that simplifies cellular profiling and accelerates bioma...

Saratoga, CA
United States
Umfula Biotech
Biotechnology-Research

Development of effective compounds across pipelines of clinical objectives.

Johannesburg, Gauten...
South Africa

Alternative Company Names

This company is also known as

CELiD BioTechnologies Inc. CELiD生物科技有限公司 CELiD बायो टेक्नोलॉजीज इंक شركة CELiD BioTechnologies Inc.